-
公开(公告)号：US20170224804A1
公开(公告)日：2017-08-10
申请号：US15347034
申请日：2016-11-09
Applicant: PFIZER INC.
Inventor： Jianxin Gu , Jin-hwan Kim , Avvari Krishna Prasad , Yu-ying Yang
IPC: A61K39/095 , A61K39/09
CPC classification number: A61K39/095 , A61K39/092 , A61K45/06 , A61K47/64 , A61K47/6415 , A61K47/646 , A61K2039/6037 , A61K2039/6068 , A61K2039/627
Abstract: The invention provides eTEC linked glycoconjugates comprising a saccharide covalently conjugated to a carrier protein through a (2-((2-oxoethyl)thio)ethyl)carbamate (eTEC) spacer, immunogenic compositions comprising such glycoconjugates, and methods for the preparation and use of such glycoconjugates and immunogenic compositions.
-
公开(公告)号：US12234259B2
公开(公告)日：2025-02-25
申请号：US18176631
申请日：2023-03-01
Applicant: Pfizer Inc.
Inventor： Mingming Han , Rajesh Kumar Kainthan , Jin-Hwan Kim , Avvari Krishna Prasad
IPC: C07K1/107 , A61K39/09 , A61K39/095 , A61K47/64 , C07H3/06 , C07K14/22 , C07K14/315 , C07K14/34 , A61K39/00
Abstract: The present disclosure relates generally to methods of preparing glycoconjugates containing a saccharide conjugated to a carrier protein by use of stable nitroxyl radical related agent/oxidant as an oxidizing agent, to immunogenic compositions comprising such glycoconjugates, and to methods for the use of such glycoconjugates and immunogenic compositions.
-
公开(公告)号：US20240033367A1
公开(公告)日：2024-02-01
申请号：US18330144
申请日：2023-06-06
Applicant: Pfizer Inc.
Inventor： Jianxin Gu , Rajesh Kumar Kainthan , Jin-Hwan Kim , Avvari Krishna Prasad , Yu-Ying Yang
CPC classification number: A61K47/6415 , A61K39/092 , A61K47/646 , A61K2039/6037
Abstract: The present invention relates generally to glycoconjugates comprising a saccharide covalently conjugated to a carrier protein through a spacer containing ((2-oxoethyl)thio)). In an aspect the invention provides oxo-eT linked glycoconjugates comprising a saccharide covalently conjugated to a carrier protein through a ((2-oxoethyl)thio) spacer having the formula (I):
wherein:
A is a group (C═X)m wherein X is S or O and m is 0 or 1;
B is a bond, O, or CH2; and when m is 0, B can also be (C═O);
R is a C2-C16 alkylene, C2-C16 heteroakylene, NH—C(═O)—C2-C16 alkylene, or NH—C(═O)—C2-C16 heteroakylene, wherein said alkylene and heteroalkylene are optionally substituted by 1, 2 or 3 groups independently selected from COOR′ where R′ is selected from H, methyl, ethyl or propyl.
The invention further relates to immunogenic compositions comprising such glycoconjugates, and to methods for the preparation and use of such glycoconjugates and immunogenic compositions.-
公开(公告)号：US11707529B2
公开(公告)日：2023-07-25
申请号：US16852697
申请日：2020-04-20
Applicant: Pfizer Inc.
Inventor： Jianxin Gu , Rajesh Kumar Kainthan , Jin-Hwan Kim , Avvari Krishna Prasad , Yu-Ying Yang
CPC classification number: A61K47/6415 , A61K39/092 , A61K47/646 , A61K2039/6037 , A61K2039/627 , C07K1/1077
Abstract: The present invention relates generally to glycoconjugates comprising a saccharide covalently conjugated to a carrier protein through a spacer containing ((2-oxoethyl)thio)). In an aspect the invention provides oxo-eT linked glycoconjugates comprising a saccharide covalently conjugated to a carrier protein through a ((2-oxoethyl)thio) spacer having the formula (I):
wherein:
A is a group (C═X)m wherein X is S or O and m is 0 or 1;
B is a bond, O, or CH2; and when m is 0, B can also be (C═O);
R is a C2-C16 alkylene, C2-C16 heteroakylene, NH—C(═O)—C2-C16 alkylene, or NH—C(═O)—C2-C16 heteroakylene, wherein said alkylene and heteroalkylene are optionally substituted by 1, 2 or 3 groups independently selected from COOR′ where R′ is selected from H, methyl, ethyl or propyl.
The invention further relates to immunogenic compositions comprising such glycoconjugates, and to methods for the preparation and use of such glycoconjugates and immunogenic compositions.-
公开(公告)号：US20220168410A1
公开(公告)日：2022-06-02
申请号：US17672126
申请日：2022-02-15
Applicant: Pfizer Inc.
Inventor： Robert G.K. Donald , Annaliesa Sybil Anderson , Laurent Oliver Chorro , Jianxin Gu , Jin-Hwan Kim , Srinivas Kodali , Jason Arnold Lotvin , Justin Keith Moran , Rosalind Pan , Avvari Krishna Prasad , Mark Edward Ruppen , Suddham Singh , Ling Chu , Scott Ellis Lomberk , Karen Kiyoko Takane , Nishith Merchant , Wei Chen
IPC: A61K39/108 , C08B37/00 , A61P31/04 , A61P37/04
Abstract: In one aspect, the invention relates to an immunogenic composition comprising modified O-polysaccharide molecules derived from E. coli lipopolysaccharides and conjugates thereof. Multivalent vaccines may be prepared by combining two or more monovalent immunogenic compositions for different E. coli serotypes. In one embodiment, the modified O-polysaccharide molecules are produced by a recombinant bacterium that includes a wzz gene.
-
Patent Agency Ranking
公开(公告)号：US20220016229A1
公开(公告)日：2022-01-20
申请号：US17312185
申请日：2019-12-09
Applicant: Pfizer Inc.
Inventor： Avvari Krishna Prasad , Jianxin Gu , Jin-Hwan Kim , Suddham Singh
Abstract: The present invention relates to new glycoconjugates comprising Streptococcus pneumoniae capsular saccharide antigens and uses thereof. Glycoconjugates of the present invention will typically comprise 2 or more saccharides antigens conjugated to the same molecule of the protein carrier. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumoccocal infections using immunogenic compositions comprising said novel glycoconjugates.
-
公开(公告)号：US20220000999A1
公开(公告)日：2022-01-06
申请号：US17474561
申请日：2021-09-14
Applicant: Pfizer Inc.
Inventor： Annaliesa Sybil Anderson , Leena Shriram Bagle , Amardeep Singh Bhupender Bhalla , Miguel Angel Garcia , Lei Hu , Lakshmi Khandke , Avvari Krishna Prasad , Cindy Xudong Yang
Abstract: The invention relates to immunogenic compositions comprising a capsular polysaccharide (CP) from Streptococcus agalactiae, commonly referred to as group B streptococcus (GBS), conjugated to a carrier protein, and optionally including an aluminum-based adjuvant. The invention further relates to methods for inducing an immune response in subjects against GBS and/or for reducing or preventing invasive GBS disease in subjects using the compositions disclosed herein. The resulting antibodies can be used to treat or prevent GBS infection via passive immunotherapy.
-
公开(公告)号：US11117928B2
公开(公告)日：2021-09-14
申请号：US16923154
申请日：2020-07-08
Applicant: Pfizer Inc.
Inventor： Mingming Han , Rajesh Kumar Kainthan , Jin-Hwan Kim , Avvari Krishna Prasad
IPC: C07K1/107 , A61K39/095 , C07K14/34 , C07K14/22 , C07K14/315 , A61K39/09 , A61K47/64 , C07H3/06 , A61K39/00
Abstract: The present disclosure relates generally to methods of preparing glycoconjugates containing a saccharide conjugated to a carrier protein by use of stable nitroxyl radical related agent/oxidant as an oxidizing agent, to immunogenic compositions comprising such glycoconjugates, and to methods for the use of such glycoconjugates and immunogenic compositions.
-
公开(公告)号：US20210121555A1
公开(公告)日：2021-04-29
申请号：US17125555
申请日：2020-12-17
Applicant: Pfizer Inc.
Inventor： Mingming Han , Avvari Krishna Prasad , David Cooper , Wendy Jo Watson
IPC: A61K39/09 , A61K39/385 , A61K39/39
Abstract: The invention relates to isolated Streptococcus pneumoniae serotype 15B capsular polysaccharide and processes for their preparation. The invention also relates to immunogenic conjugates comprising Streptococcus pneumoniae serotype 15B capsular polysaccharide covalently linked to a carrier protein, processes for their preparation and immunogenic compositions comprising them.
-
公开(公告)号：US20210023193A1
公开(公告)日：2021-01-28
申请号：US17060337
申请日：2020-10-01
Applicant: Pfizer Inc.
Inventor： Jianxin Gu , Rajesh Kumar Kainthan , Jin-Hwan Kim , Avvari Krishna Prasad , Yu-Ying Yang
IPC: A61K39/09 , A61K39/385 , A61K39/39
Abstract: The invention relates to activated Streptococcus pneumoniae serotype 10A, 22F or 33F polysaccharides and processes for their preparation. The invention also relates to immunogenic conjugates comprising Streptococcus pneumoniae serotype 10A, 22F or 33F polysaccharides covalently linked to a carrier protein, processes for their preparation and immunogenic compositions and vaccines comprising them.
-
-
-
-
-
-
-
-
-
Search Results
68
records
(took 0.025 seconds)
